These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 354830)

  • 1. Amiloride in the treatment of primary hyperaldosteronism and essential hypertension.
    Kremer D; Boddy K; Brown JJ; Davies DL; Fraser R; Lever AF; Morton JJ; Robertson JI
    Clin Exp Pharmacol Physiol Suppl; 1978; 4():55-63. PubMed ID: 354830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amiloride in the treatment of primary hyperaldosteronism and essential hypertension.
    Kremer D; Boddy K; Brown JJ; Davies DL; Fraser R; Lever AF; Morton JJ; Robertson JI
    Clin Endocrinol (Oxf); 1977 Aug; 7(2):151-7. PubMed ID: 890999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The spironolactone, amiloride, losartan, and thiazide (SALT) double-blind crossover trial in patients with low-renin hypertension and elevated aldosterone-renin ratio.
    Hood SJ; Taylor KP; Ashby MJ; Brown MJ
    Circulation; 2007 Jul; 116(3):268-75. PubMed ID: 17606839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydrochlorothiazide-amiloride versus hydrochlorothiazide alone for essential hypertension: effects on blood pressure and serum potassium level.
    Larochelle P; Logan AG
    Can Med Assoc J; 1985 Apr; 132(7):801-5. PubMed ID: 3884122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arterial blood pressure and plasma and body electrolytes in idiopathic hyperaldosteronism: a comparison with primary hyperaldosteronism (Conn's syndrome) and essential hypertension.
    Lasaridis A; Brown JJ; Davies DL; Fraser R; Robertson JI; Lever AF
    J Hypertens; 1984 Aug; 2(4):329-36. PubMed ID: 6530544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of moduretic and hydrochlorothiazide in the treatment of hypertension in African patients.
    Salako LA; Falase AO
    East Afr Med J; 1973 Jan; 50(1):38-47. PubMed ID: 4720446
    [No Abstract]   [Full Text] [Related]  

  • 7. Timolol and a hydrochlorothiazide-amiloride combination in the treatment of essential hypertension in young and middle-aged patients: a comparative study with once-daily administration.
    Lindroos M; Lehtonen A
    Int J Clin Pharmacol Ther Toxicol; 1984 Dec; 22(12):643-5. PubMed ID: 6396239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A combination of methyldopa, hydrochlorothiazide and amiloride in the treatment of essential hypertension].
    Bolzano K; Krempler F; Sandhofer F
    Acta Med Austriaca; 1984; 11(2):49-53. PubMed ID: 6377793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The therapeutic use of a new potassium-sparing diuretic, amiloride, and a converting enzyme inhibitor, MK-421, in preventing hypokalemia associated with primary and secondary hyperaldosteronism.
    Griffing GT; Melby JC
    Clin Exp Hypertens A; 1983; 5(6):779-801. PubMed ID: 6309436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amiloride in primary hyperaldosteronism.
    Griffing GT; Cole AG; Aurecchia SA; Sindler BH; Komanicky P; Melby JC
    Clin Pharmacol Ther; 1982 Jan; 31(1):56-61. PubMed ID: 7053305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of bendroflumethiazide/potassium chloride versus hydrochlorothiazide/amiloride on blood pressure and serum electrolytes in patients with mild to moderate hypertension seen in general practice.
    Jørgensen F; Bredesgaard P; Johansen P
    Pharmatherapeutica; 1986; 4(10):655-64. PubMed ID: 3602017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spironolactone and amiloride in hypertensive patients with and without aldosterone excess.
    Hoefnagels WH; Drayer JI; Smals AG; Kloppenborg PW
    Clin Pharmacol Ther; 1980 Mar; 27(3):317-23. PubMed ID: 6987022
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of arterial hypertension with a combination of hydrochlorothiazide and hydrochloride amiloride].
    da Cunha GP; Albanesi FM; Wajngarten M; Cantarelli EL
    Arq Bras Cardiol; 1983 May; 40(5):353-6. PubMed ID: 6360099
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of amiloride on the renin-aldosterone system in primary hyperaldosteronism and Bartter's syndrome.
    Griffing GT; Aurecchia SA; Sindler BH; Melby JC
    J Clin Pharmacol; 1982; 22(11-12):505-12. PubMed ID: 6761369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiclinic evaluation of the antihypertensive effect of a methyldopa, hydrochlorothiazine, and amiloride combination.
    Moncloa F; Hwang IK; Muccilli AC
    Clin Ther; 1980; 3(3):168-75. PubMed ID: 7006811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spironolactone and amiloride in the treatment of low renin hyperaldosteronism and related syndromes.
    Kremer D; Beevers DG; Brown JJ; Davies DL; Ferriss JB; Fraser R; Lever AF; Robertson JI
    Clin Sci Mol Med Suppl; 1973 Aug; 45 Suppl 1():213s-8. PubMed ID: 4361398
    [No Abstract]   [Full Text] [Related]  

  • 17. [Association of furosemide and amiloride in patients with essential hypertension. Effect on the excretion of Na, K, Cl and on urine volume].
    Chávez de Los Rios JM; Otero Cagide F; Alfaro Cano L; Gatica Laborde V
    Prensa Med Mex; 1978; 43(3-4):89-94. PubMed ID: 364462
    [No Abstract]   [Full Text] [Related]  

  • 18. Amiloride, spironolactone, and potassium chloride in thiazide-treated hypertensive patients.
    Ramsay LE; Hettiarachchi J; Fraser R; Morton JJ
    Clin Pharmacol Ther; 1980 Apr; 27(4):533-43. PubMed ID: 7357812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiclinic comparison of amiloride, hydrochlorothiazide, and hydrochlorothiazide plus amiloride in essential hypertension. Multicenter Diuretic Cooperative Study Group.
    Arch Intern Med; 1981 Mar; 141(4):482-6. PubMed ID: 7011237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Primary hyperaldosteronism--12 clinical cases].
    Telles EC; Machado FS; da Silva EP; Lutucuta S; Almeida G; Coucelo J; Vagueiro C
    Rev Port Cardiol; 1999 Sep; 18(9):801-12. PubMed ID: 10536470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.